Capnia names chairman, CEO
August 6, 2007


Palo Alto, CA - Capnia Inc. named Ernest Mario chairman and chief executive officer Monday.

Palo Alto-based Capnia said Mario joins the company from Liberty Corner, N.J.-based Reliant Pharmaceuticals Inc., where he served in the same roles, and has 40 years of experience in the pharmaceutical industry.

He is an adjunct professor of pharmacy at the University of Rhode Island and a partner with Pappas Ventures, a North Carolina-based life sciences venture capital firm.

Capnia is a privately-held drug development company focused on treatments for migraine, rhinitis and other conditions. The company is backed by Vivo Ventures and Asset Management Partners, both of Palo Alto; TeknoInvest and Alliance Venture, both of Oslo, Norway; and San Francisco-based Sagamore Bioventures.